Priority Date: 13.06.16 (US 201662349331P)

MESSENGER RNA THERAPY FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

  • Application ID: EP17734898
  • Status: Request for examination was made

Attorney

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Carpmaels & Ransford LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 174 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 13.06.2016 - Priority Date (US 201662349331P)
  • 21.12.2017 - Publication A1 (WO2017218524)
  • 17.04.2019 - Publication A1 (EP3469074)

IPC Classification